The Use of N-acetylcysteine Supplementation to Decrease Irritability in Four Youths With Autism Spectrum Disorders.

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Autism spectrum disorder (ASD) is associated with significant irritability in children and adolescents.
• N-acetylcysteine (NAC), an antioxidant and glutathione precursor, is being investigated for neuropsychiatric conditions.
• Previous research on NAC for ASD irritability was limited to milder cases in outpatient settings.

Observation:

• This case series examined NAC in four adolescents (14-17 years) with ASD and severe irritability (Aberrant Behavior Checklist-Irritability scores ≥ 20).
• These participants had previously undergone trials of other psychotropic medications.
• NAC was administered to assess its tolerability and effects on irritability and related behaviors.

Findings:

• N-acetylcysteine (NAC) was generally well-tolerated in all four adolescent participants with ASD.
• A reduction in irritability symptoms and/or antipsychotic medication dosages was observed.
• The study acknowledges the limitations of a case series, preventing definitive conclusions on NAC's efficacy due to the lack of a control group.

Implications:

• NAC shows promise as a potentially well-tolerated intervention for severe irritability in adolescents with ASD.
• Further controlled trials are warranted to establish the efficacy of NAC in this population.
• Findings suggest NAC could be a valuable addition to treatment strategies for challenging behaviors in ASD.